GH · Guardant Health, Inc.
$157.58
-5.60 (-3.43%)
At close · Aug 6
Market Cap
$21.15B
Shares
134.20M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding GH
549 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 3,958,539 | $365,650,247 | 0.02% | Long | 2026-03-31 | |
| iShares Russell 2000 ETF | — | 3,033,710 | $280,223,793 | 0.39% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 2,873,276 | $265,404,504 | 0.16% | Long | 2026-03-31 | |
| VANGUARD U.S. GROWTH FUND | — | 1,716,540 | $222,618,073 | 0.47% | Long | 2026-05-31 | |
| Growth Fund of America | — | 1,263,832 | $163,906,372 | 0.05% | Long | 2026-05-31 | |
| Franklin Dynatech Fund | — | 1,750,000 | $161,647,500 | 0.65% | Long | 2026-03-31 | |
| FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH | — | 1,639,500 | $151,440,615 | 3.60% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 1,608,489 | $148,576,129 | 0.38% | Long | 2026-03-31 | |
| Eventide Gilead Fund | — | 1,605,290 | $148,280,637 | 5.53% | Long | 2026-03-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 1,516,883 | $140,114,483 | 1.10% | Long | 2026-03-31 | |
| Invesco Discovery Fund | — | 1,058,225 | $137,241,200 | 1.75% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,438,088 | $132,836,189 | 0.16% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 1,228,172 | $106,949,218 | 0.33% | Long | 2026-04-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,055,988 | $97,541,612 | 0.90% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 1,012,897 | $93,561,296 | 0.77% | Long | 2026-03-31 | |
| Growth Fund | — | 968,653 | $89,474,478 | 0.18% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 664,487 | $86,177,319 | 0.20% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 638,073 | $82,751,687 | 0.47% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 619,437 | $80,334,785 | 0.35% | Long | 2026-05-31 | |
| Federated Hermes Kaufmann Fund | — | 916,481 | $79,807,165 | 1.71% | Long | 2026-04-30 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 859,232 | $79,367,260 | 0.96% | Long | 2026-03-31 | |
| SMALLCAP World Fund Inc | — | 772,356 | $71,342,524 | 0.09% | Long | 2026-03-31 | |
| Columbia Small Cap Growth Fund | — | 539,457 | $69,962,178 | 1.91% | Long | 2026-05-31 | |
| Lord Abbett Growth Leaders Fund | — | 800,958 | $69,747,423 | 0.92% | Long | 2026-04-30 | |
| Eventide Healthcare & Life Sciences Fund | — | 700,321 | $64,688,651 | 4.07% | Long | 2026-03-31 | |
| Hood River Small-Cap Growth Fund | — | 667,252 | $61,634,067 | 1.18% | Long | 2026-03-31 | |
| Capital Group Growth ETF | — | 472,773 | $61,313,930 | 0.25% | Long | 2026-05-31 | |
| Select Health Care Portfolio | — | 460,000 | $59,657,400 | 1.03% | Long | 2026-05-31 | |
| Select Medical Technology and Devices Portfolio | — | 428,000 | $55,507,320 | 1.86% | Long | 2026-05-31 | |
| Strategic Advisers U.S. Total Stock Fund | — | 412,646 | $53,516,060 | 0.05% | Long | 2026-05-31 | |
| Federated Hermes Kaufmann Small Cap Fund | — | 610,000 | $53,118,800 | 1.85% | Long | 2026-04-30 | |
| LORD ABBETT DEVELOPING GROWTH FUND INC | — | 599,531 | $52,207,159 | 2.35% | Long | 2026-04-30 | |
| Bridge Builder Small/Mid Cap Growth Fund | — | 541,591 | $50,026,761 | 0.54% | Long | 2026-03-31 | |
| Small Cap Growth Fund | — | 539,683 | $46,995,596 | 0.93% | Long | 2026-04-30 | |
| Schwab U.S. Mid-Cap ETF | — | 348,281 | $45,168,563 | 0.31% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 337,089 | $43,717,072 | 0.23% | Long | 2026-05-31 | |
| AB Small Cap Growth Portfolio | — | 501,304 | $43,653,552 | 1.49% | Long | 2026-04-30 | |
| Fidelity Blue Chip Growth Fund | — | 497,232 | $43,298,963 | 0.05% | Long | 2026-04-30 | |
| ARK Genomic Revolution ETF | — | 496,000 | $43,191,680 | 3.49% | Long | 2026-04-30 | |
| Invesco Discovery Mid Cap Growth Fund | — | 428,074 | $37,276,684 | 0.56% | Long | 2026-04-30 | |
| Fidelity Enhanced Small Cap ETF | — | 385,582 | $35,616,209 | 0.87% | Long | 2026-03-31 | |
| Balanced Fund | — | 396,501 | $34,527,307 | 0.52% | Long | 2026-04-30 | |
| Invesco Main Street Small Cap Fund | — | 372,810 | $34,436,460 | 1.56% | Long | 2026-03-31 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 389,787 | $33,942,652 | 1.26% | Long | 2026-04-30 | |
| Fidelity Small Cap Growth Fund | — | 388,310 | $33,814,035 | 0.40% | Long | 2026-04-30 | |
| SmallCap Growth Fund I | — | 376,019 | $32,743,735 | 1.40% | Long | 2026-04-30 | |
| Voya Small Cap Growth Fund | — | 251,658 | $32,637,526 | 1.54% | Long | 2026-05-31 | |
| Columbia Cornerstone Growth Fund | — | 371,684 | $32,366,243 | 0.50% | Long | 2026-04-30 | |
| Columbia Select Mid Cap Growth Fund | — | 244,557 | $31,716,597 | 1.43% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 243,505 | $31,580,163 | 0.02% | Long | 2026-05-31 |
Showing 1–50 of 549 positions
Key facts
CIK
1576280
CUSIP
40131M109
13F (30d)
219 filings
194 filers
Visit website
Investor relations